Viridian Therapeutics, Inc.\DE (VRDN) Return on Sales (2013 - 2026)
Viridian Therapeutics, Inc.\DE (VRDN) posted quarterly Return on Sales of 7.93% for Q1 2026, up 515.0% year-over-year from 1.29% in Q1 2025, and down 5.35% quarter-over-quarter from 7.52% in Q4 2025.
Viridian Therapeutics, Inc.\DE (VRDN) Return on Sales (2013 - 2026) Analysis & Trends
Viridian Therapeutics, Inc.\DE's Return on Sales history runs 14 years deep, the most recent figure standing at 7.93% for Q1 2026.
- In Q1 2026, Return on Sales rose 515.0% year-over-year to 7.93%; the TTM figure through Mar 2026 stood at 0.05% (up 1113.0% YoY), while the FY2025 annual figure was 0.09%, up 1567.0% from the prior year.
- Return on Sales for Q1 2026 stood at 7.93%, down from 7.52% in the prior quarter.
- The five-year high for Return on Sales was 0.0% in Q3 2025, with the low at 14.89% in Q2 2025.
- The 5-year median for Return on Sales is 7.65% (2023), against an average of 7.24%.
- The sharpest annual moves came in 2023 and 2025: Return on Sales tumbled 735 bps in 2023, then surged 1063 bps in 2025.
- Viridian Therapeutics, Inc.\DE's Return on Sales stood at 4.34% in 2022, then tumbled by 169 bps to 11.69% in 2023, then advanced by 6 bps to 10.98% in 2024, then jumped by 32 bps to 7.52% in 2025, then slipped by 5 bps to 7.93% in 2026.
- Business Quant data shows VRDN's Return on Sales at 7.93% in Q1 2026, 7.52% in Q4 2025, and 0.0% in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROS (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 0.00% |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 0.00% |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | 0.00% |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 0.00% |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | 0.00% |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 0.00% |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 0.00% |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 0.00% |
| 10 | Viridian Therapeutics, Inc.\DE | 2.50 Bn | 2.50 Bn | - | -5.66% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -5.66% |
| Mar 31, 2026 | -7.93% |
| Dec 31, 2025 | -7.52% |
| Sep 30, 2025 | 0.00% |
| Jun 30, 2025 | -14.89% |
| Mar 31, 2025 | -13.08% |
| Dec 31, 2024 | -10.99% |
| Sep 30, 2024 | -10.64% |
| Jun 30, 2024 | -10.13% |
| Mar 31, 2024 | -8.01% |
| Dec 31, 2023 | -11.69% |
| Sep 30, 2023 | -6.62% |
| Jun 30, 2023 | -7.65% |
| Mar 31, 2023 | -6.96% |
| Dec 31, 2022 | -4.34% |
| Sep 30, 2022 | -0.24% |
| Jun 30, 2022 | -1.15% |
| Mar 31, 2022 | -1.19% |
| Dec 31, 2021 | -1.36% |
| Sep 30, 2021 | -0.68% |